Sorafenib-mediated Mcl-1 and cFLIPL down-regulation synergistically increase TRAIL lethality in human leukemia cells
Year: 2007
Type: article
Source: Molecular Cancer Therapeutics
Institution: Virginia Commonwealth University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2258024356
